Status:

ACTIVE_NOT_RECRUITING

Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy

Lead Sponsor:

University Hospital, Toulouse

Conditions:

Diabete Type 1

Eligibility:

All Genders

18+ years

Brief Summary

The prevalence of eating disorders is particularly high among people with type 1 diabetes (T1D). These abnormalities, such as "diabulimia," are frequently responsible for poor insulin therapy manageme...

Detailed Description

The prevalence of eating disorders (EDs) and problematic eating behaviors (PEBs) is particularly high among people with type 1 diabetes (T1D), affecting 20 to 50% of women and 5 to 25% of men among yo...

Eligibility Criteria

Inclusion

  • Patient diagnosed with type 1 diabetes.
  • Patient with a CGM device for more than 3 months with \> 80% of data captured in the last month.
  • Indication for the implementation of a BF device as part of routine care, in the Diabetology, Metabolic Diseases and Nutrition Department of the Toulouse University Hospital (initiating center).

Exclusion

  • Pregnant or breastfeeding women, or those planning to become pregnant within 6 months of inclusion.
  • History of obesity surgery or a preparatory program for obesity surgery planned during the study period.
  • Pharmacological treatment likely to significantly influence food intake and body weight, whether ongoing or discontinued within the last 3 months (e.g., GLP-1R agonist): Liraglutide (Victoza®, Saxenda®), Semaglutide (Ozempic®, Wegovy®), Dulaglutide (Trulicity®), Tirzepatde (Mounjaro®), Orlistat (Xenical®)
  • Eating disorder requiring specific treatment in the previous 12 months.
  • Refusal or inability to consent to participate.
  • Persons under legal protection (guardianship, curatorship, or court-ordered protection).

Key Trial Info

Start Date :

September 4 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 28 2027

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT07151924

Start Date

September 4 2025

End Date

February 28 2027

Last Update

September 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Diabetology, Metabolic Diseases and Nutrition Department Rangueil Hospital, Toulouse University Hospital 1 avenue du Pr Jean Poulhès

Toulouse, France, 31059

Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy | DecenTrialz